A detailed history of Kynam Capital Management, LP transactions in Burning Rock Biotech LTD stock. As of the latest transaction made, Kynam Capital Management, LP holds 9,640,914 shares of BNR stock, worth $62.2 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
9,640,914
Previous 8,694,426 10.89%
Holding current value
$62.2 Million
Previous $8.09 Million 12.96%
% of portfolio
0.74%
Previous 0.9%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.68 - $0.97 $643,611 - $918,093
946,488 Added 10.89%
9,640,914 $7.04 Million
Q4 2023

Feb 14, 2024

BUY
$0.72 - $1.13 $139,986 - $219,701
194,426 Added 2.29%
8,694,426 $8.09 Million
Q2 2023

Aug 14, 2023

BUY
$2.15 - $3.16 $1.03 Million - $1.51 Million
479,375 Added 5.98%
8,500,000 $18.3 Million
Q1 2023

May 15, 2023

BUY
$2.16 - $3.47 $1.36 Million - $2.18 Million
629,044 Added 8.51%
8,020,625 $22.5 Million
Q4 2022

Feb 14, 2023

BUY
$1.73 - $2.95 $1.19 Million - $2.03 Million
687,718 Added 10.26%
7,391,581 $16.6 Million
Q3 2022

Nov 14, 2022

BUY
$2.39 - $3.96 $5.75 Million - $9.52 Million
2,403,863 Added 55.9%
6,703,863 $16 Million
Q2 2022

Aug 15, 2022

BUY
$1.75 - $10.44 $6.17 Million - $36.8 Million
3,526,886 Added 456.19%
4,300,000 $12.5 Million
Q1 2022

May 13, 2022

BUY
$6.7 - $10.23 $2.62 Million - $4 Million
390,650 Added 102.14%
773,114 $7.18 Million
Q4 2021

Feb 14, 2022

BUY
$9.43 - $17.14 $3.61 Million - $6.56 Million
382,464 New
382,464 $3.65 Million

Others Institutions Holding BNR

About Burning Rock Biotech Ltd


  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $678M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.